Aortic plaque size and endometrial response in cholesterol-fed rabbits treated with estrogen plus continuous or sequential progestin

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1930-1937

  Brehme, Ute ^a   Bruck, Birgit ^a   Gugel, Natalia ^a   Wehrmann, Manfred ^a   Hanke, Sybille ^a   Finking, Gerald ^a   Schmahl, Friedrich W ^a   Hanke, Hartmut ^a  

^a Dept of Occup and Social Medicine ^*

Author keywords

Atherosclerosis; Endometrium; Estrogen; Progestin; Rabbits

Indexed keywords

ESTRADIOL VALERATE; HYDROXYPROGESTERONE CAPROATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; DOSE RESPONSE; ENDOMETRITIS; FEMALE; HORMONAL THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032813835     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1930     Document Type: Article

References (49)

1. White CR, Darley-Usmar V, Oparil S. Gender and cardiovascular disease: Recent insights. Trends Cardiovasc Med. 1997;7:94-100.
2. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
3. Sullivan JM, Fowlkes LP. The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol. 1996;87(suppl 2):36S-43S.
4. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75: 1102-1109.
5. Walsh BW, Schiff I, Rosner B, Greenherg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325: 1196-1204.
6. Karjalainen A, Heikkinen J, Savolainen MJ, Bäckström A-C, Salinto M, Kesäniemi YA. Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy. Br J Obstet Gynaecol. 1997;104(suppl 16):38-43.
7. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
8. McCrohon JA, Adams MR, McCredie RJ, Robinson J, Pike A, Abbey M, Keech AC, Celermajer DS. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol. 1996;45:435-441.
9. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet. 1991;338:274-277.
10. Creasy GW, Kafrissen ME, Upmalis D. Review of the endometrial effects of estrogens and progestins. Obstet Gynecol Surv. 1992;47:654-678.
11. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208.
12. Prough SG, Aksel S, Wiebe RH, Shepherd J. Continuous estrogen/ progestin therapy in menopause. Am J Obstet Gynecol. 1987;157: 1449-1453.
13. Luciano AA, Turksoy RN, Carleo J, Hendrix JW. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy. Obstet Gynecol. 1988;71:39-43.
14. Soma MR, Baetta R, Crosignani PG. The menopause and lipid metabolism: Strategies for cardiovascular disease prevention. Curr Opin Lipidol. 1997;8:229-235.
15. Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med. 1997;337:595-601.
16. Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women: Influence of various progestogens and duration of therapy. Arch Intern Med. 1996;156:1693-1700.
17. Lahdenperä S. Puolakka J, Pyörälä T, Luotola H. Taskinen M-R. Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles: Comparison of transdermal and oral treatment regimens. Atherosclerosis. 1996;122:153-162.
18. Medical Research Council's General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. BMJ. 1996; 312:473-478.
19. Grodstein F, Stampfer MJ, Manson JE, Colditz GA. Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996;335: 453-461.
20. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
21. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88: 1995-2002.
22. McKinney KA, Duell PB, Wheaton DL, Hess DL, Patton PE, Spies HG, Burry KA. Differential effects of subcutaneous estrogen and progesterone on low-density lipoprotein size and susceptibility to oxidation in postmenopausal rhesus monkeys. Fertil Steril. 1997;68:525-530.
23. Clarkson TB. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys. Fertil Steril. 1994;62:147S-151S.
24. Williams JK, Honoré EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 1994;24:1757-1761.
25. Hanke H, Hanke S, Finking G, Muhic-Lohrer A, Muck AO, Schmahl FW, Haasis R, Hombach V. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits: quantification of cellular proliferation by bromodeoxyuridine. Circulation. 1996;94: 175-181.
26. Manning JM, Campos G, Edwards IJ, Wagner WD, Wagner JD, Adams MR, Parks JS. Effects of hormone replacement modalities on low density lipoprotein composition and distribution in ovariectomized cynomolgus monkeys. Atherosclerosis. 1996;121:217-229.
27. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:217-221.
28. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
29. Hough JL, Zilversmit DB. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 1986; 6:57-63.
30. Adams MR, Williams JK, Clarkson TB, Jayo MJ. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys. Baillières Clin Obstet Gynaecol. 1991;5:915-934.
31. Haarbo J, Svendsen OL, Christiansen C. Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res. 1992;70:1198-1202.
32. Batra S, Källstrand K. Are there cyclic variations in estradiol secretion in the non-pregnant rabbit? Experientia. 1979;35:699-701.
33. Ginsburg ES, Mello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M, Gao X, Sholar JW. Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA. 1996;276:1747-1751.
34. Kuhl H. Pharmacokinetics of oestrogens and progestogens. Maturitas. 1990;2:171-197.
35. Rijpkema AHM, van der Sanden AA, Ruijs AHC. Effects of postmenopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas. 1990;12:259-285.
36. Fischer GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 1985;54:177-185.
37. Kushwaha RS, Hazzard WR. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 1981; 30:359-366.
38. Crook D. The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy. Br J Obstet Gynaecol. 1997;104(suppl 16):4-13.
39. Crook D, Cust MP, Gangar JCF, Worthington M, Hillard TC, Stevenson JC, Whitehead MI, Wynn V. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol. 1992;166:950-955.
40. Tikkanen MJ. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors. Maturitas. 1996;23: 209-216.
41. Haarbo J. Hormone replacement therapy and cardiovascular disease: the rabbit model. Br J Obstet Gynaecol. 1996;103(suppl 13):49-52.
42. Prelevic GM, Jacobs HS. Menopause and post-menopause. Baillières Clin Endocrinol Metab. 1997;11:311-340.
43. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304-313.
44. Hirvonen E. Progestins. Maturitas. 1996;23(suppl):S13-S18.
45. Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium. and lipids of continuous hormones as replacement therapy (CHART Study): a randomized controlled trial. JAMA. 1996;276:1397-1403.
46. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1996; 275:370-375.
47. Ferenczy A, Gelfand MM. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone. Maturitas. 1997;26:219-226.
48. Bjarnason NH, Haarbo J, Byrjalsen I, Kauffman RF, Christiansen C. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation. 1997;96:1964-1969.
49. Elhage R, Arnal J-F, Pieraggi M-T, Duverger N, Fiévet C, Faye J-C, Bayard F. 17β-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 1997;17:2679-2684.